Last few months have been topsy-turvy for most of the pharma/chemical/tech heavy portfolios. That was because market has been rotating the sectors in fancy at breakneck speed. Often we could not catch it or if caught it then did not put the money at work on time. That is also reflected on portfolio being stagnant. …